Patient-specific viscosity
in coronary diagnostics

Hemodynes is building an FFR-CT integrating the patient's blood viscosity, measured at the point of care.

< 1 mL Blood required
< 1 min Measurement time
1–60 cP Range covered
Platform Hemodynes platform — personalized FFR-CT H1 viscometer Hemodynes H1 viscometer
The clinical challenge
The gray zone

Precision around the threshold is critical — it changes patient management. 20% of patients with intermediate stenosis fall in this zone.

The insight
Blood viscosity

Blood viscosity varies threefold across individuals and directly affects FFR-CT calculations. Yet current models still treat it as a constant.

Our answer
H1 + SaMD duo

Feed the actual measured viscosity into the hemodynamic model to personalize FFR-CT.

Availability
H1 viscometer

Our H1 viscometer will be available for Research Use Only from 2027.

Hardware + software

The H1 point-of-care viscometer feeds the modeling platform with the patient's actual blood viscosity, delivering patient-specific hemodynamic indicators.

H1 viscometer

H1 — Point-of-care viscometer

Fast, miniature, plug-and-play.

  • Measurement in under one minute
  • Less than 1 mL of whole blood or plasma
  • 1–60 cP range, patented
  • Available for Research Use Only from 2027
Technical specifications
Hemodynes platform — personalized FFR-CT

Hemodynamic platform

Personalized FFR-CT + patient-specific Wall Shear Stress.

  • Pairs coronary CT anatomy with measured viscosity
  • Personalized FFR-CT computation
  • WSS mapping across the coronary tree
  • Standard vs. personalized comparison
Methodology

Backing our program

French POC
ICOSA
Paris Biotech Santé
WILCO
50Partners
BPI France
French POC
ICOSA
Paris Biotech Santé
WILCO
50Partners
BPI France

The founders

Dr. Alexandre de Tilly
The inventor
Dr. Alexandre de Tilly
CSO & Co-founder
PhD with 20+ years of research on light, fluids, and complex liquids. Inventor of both Hemodynes patents.
Fabien Delivré
The pilot
Fabien Delivré
CEO & Co-founder
Engineer with 20+ years managing international programs and strategy consulting.
Emmanuel Aucouturier
The builder
Emmanuel Aucouturier
CCO & Co-founder
20+ years of entrepreneurship, including medical device development.

Bringing patient-specific viscosity into your research?

Clinician-researchers, labs, CROs: let's talk scientific partnership, technical demo, or RUO access to the viscometer.

Get in touch